Original Query: "Hepatitis B, Chronic"
Previous Study | Return to List | Next Study

Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00524173
Recruitment Status : Terminated
First Posted : September 3, 2007
Last Update Posted : October 6, 2017
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) )

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Terminated
  Primary Completion Date : February 16, 2017
  Study Completion Date : February 16, 2017

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 March 20, 2018